About Manisha Chatterjee
Since she was young, Manisha has had a strong interest in the stock market. She majored in Economics in college and has a passion for writing, which has led to her career as a research analyst.
Manisha’s goal is to help individual investors succeed in the stock market. She uses her knowledge in fundamental analysis to evaluate companies and determine if they are worthwhile investments.
Recent Articles By Manisha Chatterjee
Is FedEx a Good Air Freight Stock to Add to Your Portfolio?
FedEx (FDX) has generated significant returns over the past few months as the company benefited from a pandemic-driven surge in e-commerce activities and played an important role in delivering COVID-19 vaccines. But even though the company is still benefiting from vaccine shipments, does the stock have the potential to deliver further upside? Read on.
Does Evofem Biosciences Deserve a Place in Your Portfolio?
Evofem Biosciences (EVFM) has been taking steps to increase awareness about its FDA-approved product—Phexxi. However, the stock has been losing value over the past year on several concerns. So, let’s find out if it is wise to bet on the stock now. Read on.
Should You Buy the Dip in Ocugen?
Ocugen’s (OCGN) share price plunged sharply following the company’s announcement on June 10 that it will pursue a BLA rather than an EUA for Bharat Biotech’s COVID-19 vaccine candidate COVAXIN. Moreover, can OCGN’s stock rebound by relying on its pipeline of products that are focused on gene therapies to cure eye diseases? Let’s find out.
Down 12% Over the Past Month, is Now a Good Time to Scoop Up Gap Stock?
Gap’s (GPS) shares have declined 12% over the past month following the company’s sale of Janie and Jack and its proposed sale of Intermix. But the company has assured the market that these transactions are part of its Power Plan 2023. So, the question is, given the increasing foot traffic at GPS’ retail stores and its strong digital presence, is it wise to buy the dip in the stock? Let’s find out.
Should Mosaic be in Your Portfolio?
Crop nutrient company Mosaic (MOS) has generated significant returns over the past year on increased demand and pricing in the agricultural fertilizer market. Because strong demand from key crop-growing regions and rising input costs are expected to continue driving fertilizer prices up, is MOS well positioned to move higher? Read on to learn more.
Should You Buy the Dip in HP Stock?
The price of HP’s (HPQ) shares has declined by more than 15% since hitting its $36 all-time high last month on speculation that global semiconductor chip shortage will have a negative impact on the pandemic-driven exponential growth of personal computer sales. Nevertheless, HPQ reported impressive financials in its fiscal second quarter, which ended April 30, 2021. And in June, HPQ acquired HyperX, the gaming division of Kingston Technology Company. So, is the stock’s current price level a good entry point? Let’s find out.
Is Second Sight Medical Products a Winner in the Healthcare Sector?
Second Sight Medical Products (EYES) has found a market niche for itself in the healthcare space developing implantable visual prosthetics to treat sight-impaired people. With the U.S. FDA approval for its Argus 2s Retinal Prosthesis System in hand, can the stock keep soaring in the coming months? Let’s find out.
Is Tesla a Buy Under $600?
Electric vehicle (EV) maker Tesla’s (TSLA) shares are currently trading significantly below their $900.40 all-time high, which they hit in January 2021. The price decline can be attributed primarily to the problems TSLA is facing because of a global semiconductor shortage. The question is, given the EV industry’s immense growth potential and TSLA’s dominant position in the market, is it wise to buy the stock at the current price level? Let’s find out.
Investors Should Consider Scooping Up Kohl’s Right Now, Here’s Why
Omni channel retail company Kohl's (KSS) has grown its business significantly over the past few months, launching new collections and forging strategic partnerships. So, we think it is wise to bet on the stock now because it is trading at an attractive valuation considering its solid financials and immense growth potential. Let’s take a closer look at KSS.